Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
199.59
+2.35 (1.19%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of $12.09 billion as of September 18, 2025. Its market cap has increased by 49.93% in one year.
Market Cap
12.09B
Enterprise Value
12.44B
1-Year Change
49.93%
Ranking
Category
Stock Price
$199.59
Market Cap Chart
Since January 28, 2015, Ascendis Pharma's market cap has increased from $448.80M to $12.09B, an increase of 2,592.97%. That is a compound annual growth rate of 36.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 12.11B | 52.92% |
| Dec 31, 2024 | 7.92B | 9.08% |
| Dec 29, 2023 | 7.26B | 4.27% |
| Dec 30, 2022 | 6.96B | -3.83% |
| Dec 31, 2021 | 7.24B | -17.63% |
| Dec 31, 2020 | 8.79B | 32.38% |
| Dec 31, 2019 | 6.64B | 152.21% |
| Dec 31, 2018 | 2.63B | 80.76% |
| Dec 29, 2017 | 1.46B | 185.54% |
| Dec 30, 2016 | 510.20M | 10.84% |
| Dec 31, 2015 | 460.30M | 2.56% |
| Jan 28, 2015 | 448.80M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 683.45B |
| Johnson & Johnson | 426.64B |
| AbbVie | 390.18B |
| UnitedHealth Group | 307.29B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 232.93B |